117 related articles for article (PubMed ID: 26775082)
1. Partner status and survival after cancer: A competing risks analysis.
Dasgupta P; Turrell G; Aitken JF; Baade PD
Cancer Epidemiol; 2016 Apr; 41():16-23. PubMed ID: 26775082
[TBL] [Abstract][Full Text] [Related]
2. Competing mortality risks among women aged 50-79 years when diagnosed with invasive breast cancer, Queensland, 1997-2012.
Dasgupta P; Aitken JF; Pyke C; Baade PD
Breast; 2018 Oct; 41():113-119. PubMed ID: 30029053
[TBL] [Abstract][Full Text] [Related]
3. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
He VY; Condon JR; Baade PD; Zhang X; Zhao Y
Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
[TBL] [Abstract][Full Text] [Related]
4. After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales.
Tervonen HE; Walton R; You H; Baker D; Roder D; Currow D; Aranda S
BMC Cancer; 2017 Jun; 17(1):398. PubMed ID: 28577351
[TBL] [Abstract][Full Text] [Related]
5. Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data.
Wright CM; Nowak AK; Halkett G; Moorin RE
BMC Public Health; 2020 Jun; 20(1):1002. PubMed ID: 32586298
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks.
Thomas AA; Pearce A; Sharp L; Gardiner RA; Chambers S; Aitken J; Molcho M; Baade P
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e31-e40. PubMed ID: 27558311
[TBL] [Abstract][Full Text] [Related]
7. An analysis of competing mortality risks among colorectal cancer survivors in Queensland, 1996-2009.
Dasgupta P; Youlden DR; Baade PD
Cancer Causes Control; 2013 May; 24(5):897-909. PubMed ID: 23408244
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the changes in survival inequality for Indigenous people diagnosed with cancer in Queensland, Australia.
Baade PD; Dasgupta P; Dickman PW; Cramb S; Williamson JD; Condon JR; Garvey G
Cancer Epidemiol; 2016 Aug; 43():1-8. PubMed ID: 27186865
[TBL] [Abstract][Full Text] [Related]
9. Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007.
Marashi-Pour S; Morrell S; Cooke-Yarborough C; Arcorace M; Baker D
Aust N Z J Public Health; 2012 Oct; 36(5):441-5. PubMed ID: 23025365
[TBL] [Abstract][Full Text] [Related]
10. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
Shen W; Sakamoto N; Yang L
Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
12. Estimating the change in life expectancy after a diagnosis of cancer among the Australian population.
Baade PD; Youlden DR; Andersson TM; Youl PH; Kimlin MG; Aitken JF; Biggar RJ
BMJ Open; 2015 Apr; 5(4):e006740. PubMed ID: 25869684
[TBL] [Abstract][Full Text] [Related]
13. Non-cancer mortality among people diagnosed with cancer (Australia).
Baade PD; Fritschi L; Eakin EG
Cancer Causes Control; 2006 Apr; 17(3):287-97. PubMed ID: 16489536
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends in net and crude probability of death from cancer and other causes in the Australian population, 1984-2013.
Dasgupta P; Cramb S; Kou K; Yu XQ; Baade PD
Cancer Epidemiol; 2019 Oct; 62():101568. PubMed ID: 31330423
[TBL] [Abstract][Full Text] [Related]
15. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
16. Spatial inequalities in colorectal and breast cancer survival: premature deaths and associated factors.
Cramb SM; Mengersen KL; Turrell G; Baade PD
Health Place; 2012 Nov; 18(6):1412-21. PubMed ID: 22906754
[TBL] [Abstract][Full Text] [Related]
17. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
Green AC; Baade P; Coory M; Aitken JF; Smithers M
J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
[TBL] [Abstract][Full Text] [Related]
18. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India.
Yeole BB; Kumar AV
Asian Pac J Cancer Prev; 2004; 5(2):175-82. PubMed ID: 15244521
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
Shen W; Sakamoto N; Yang L
BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]